A. Rigby

发表

The discovery of CCR3/H1 dual antagonists with reduced hERG risk.

B. Springthorpe, P. Barton, R. Riley, 2012, Bioorganic & medicinal chemistry letters.

From ATP to AZD6140: the discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosis.

P. Leeson, B. Springthorpe, P. Barton, 2007, Bioorganic & medicinal chemistry letters.

Discovery and evolution of phenoxypiperidine hydroxyamide dual CCR3/H₁ antagonists. Part I.

B. Springthorpe, R. Riley, H. Beaton, 2012, Bioorganic & medicinal chemistry letters.